Mellitus, LLC
Medical Devices - , Massachusetts, United States
Mellitus, LLC Employees
Mellitus, LLC Senior Management
Mellitus, LLC Details
Developing the new gold standard for diabetes testingMellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development. Mellitus' lead product candidate is a test for Gestational Diabetes Mellitus (GDM).The Mellitus patented Technology is based on the measurement of a novel biomarker called Glycated CD59 (GCD59). Mellitus' Founders discovered the role of GCD59 in the complications of diabetes and developed the method to measure GCD59 as a diagnostic test. The Mellitus Technology is exclusively licensed to the Company from Harvard University.
Mellitus, LLC Technologies
Email Providers
Gmail
Load Balancers
Apache
CMS
Drupal
Other
Google Apps
Hosting
GoDaddy Hosting
CSS and JavaScript Libraries
Bootstrap Framework